The functional relationship of the interleukins

doi:10.1084/jem.151.6.1551

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Smith, K. A.
	Articles by Favata, M. F.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Smith, K. A.
	Articles by Favata, M. F.


Social Bookmarking

	What's this?

ARTICLES

The functional relationship of the interleukins

KA Smith, LB Lachman, JJ Oppenheim and MF Favata

The mechanism of the lymphoproliferative effect of the macrophage product lymphocyte-activating factor [LAF(IL1] appears to be mediated by the stimulation of the release of T cell growth factor [TCGF(IL2)] by T cells. The magnitude of the resultant T cell proliferative clonal expansion is thus dependent upon the quantity of both LAF(IL1) and TCGF(IL2) induced by antigen or lectin stimulation. These observations, coupled with the ability to measure the production and actions of these hormone-like lymphokines, should allow for increased insight into the mode of action of immunoenhancing and immunosuppressive agents, as well as for new therapeutic approaches to disease states involving T lymphocytes.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Baer, M. R., George, S. L., Caligiuri, M. A., Sanford, B. L., Bothun, S. M., Mrozek, K., Kolitz, J. E., Powell, B. L., Moore, J. O., Stone, R. M., Anastasi, J., Bloomfield, C. D., Larson, R. A. (2008). Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720. JCO 26: 4934-4939 [Abstract] [Full Text]
Farag, S. S., George, S. L., Lee, E. J., Baer, M., Dodge, R. K., Becknell, B., Fehniger, T., Silverman, L. R., Crawford, J., Bloomfield, C. D., Larson, R. A., Schiffer, C. A., Caligiuri, M. A. (2002). Postremission Therapy with Low-dose Interleukin 2 with or without Intermediate Pulse Dose Interleukin 2 Therapy Is Well Tolerated in Elderly Patients with Acute Myeloid Leukemia: Cancer and Leukemia Group B Study 9420. Clin. Cancer Res. 8: 2812-2819 [Abstract] [Full Text]
Griffin, W. S. T., Mrak, R. E. (2002). Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J. Leukoc. Biol. 72: 233-238 [Abstract] [Full Text]
Panus, J. F., McHeyzer-Williams, L. J., McHeyzer-Williams, M. G. (2000). Antigen-specific T Helper Cell Function: Differential Cytokine Expression in Primary and Memory Responses. JEM 192: 1301-1316 [Abstract] [Full Text]
Xing, L., Guo, J., Wang, X. (2000). Induction and Expression of {beta}-Calcitonin Gene-Related Peptide in Rat T Lymphocytes and Its Significance. J. Immunol. 165: 4359-4366 [Abstract] [Full Text]
Freund, Y. R., Dousman, L., MacGregor, J. T., Mohagheghpour, N. (2000). Oral Treatment with Trimethoprim-Sulfamethoxazole and Zidovudine Suppresses Murine Accessory Cell-Dependent Immune Responses. Toxicol Sci 55: 335-342 [Abstract] [Full Text]
Smith, K. (1988). Interleukin-2: inception, impact, and implications. Science 240: 1169-1176 [Abstract]
Unanue, E., Allen, P. (1987). The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236: 551-557 [Abstract]